Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 15, 2019 - Issue 12
Submit an article Journal homepage
646
Views
2
CrossRef citations to date
0
Altmetric
Letter

Mastoiditis with Streptococcus pneumoniae serotype 19A in one-dose PCV13 vaccinated three-month-old infant

B. GülhanDepartment of Pediatric Infectious Diseases, University of Health Sciences, Ankara Child Health and Diseases Hematology Oncology Training and Research Hospital, Ankara, TurkeyCorrespondence[email protected]
,
S. Kanik-YuksekDepartment of Pediatric Infectious Diseases, University of Health Sciences, Ankara Child Health and Diseases Hematology Oncology Training and Research Hospital, Ankara, Turkey
&
A. Ozkaya-ParlakayDepartment of Pediatric Infectious Diseases, University of Health Sciences, Ankara Child Health and Diseases Hematology Oncology Training and Research Hospital, Ankara, Turkey
Pages 2917-2918 | Received 30 Apr 2019, Accepted 27 May 2019, Published online: 26 Jul 2019

References

  • Pichichero ME, Casey JR and Almudevar A. Reducing the frequencyof acute otitis media by individualized care. Pediatr Infect Dis J. 2013;32:473–78. doi:10.1097/INF.0b013e3182862b57.
  • Rodgers GL, Arguedas A, Cohen R, Dagan R. Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines. Vaccine. 2009;27:3802–10. doi:10.1016/j.vaccine.2009.04.021.
  • Bluestone CD, Klein JO. Intratemporal complications and sequelae of otitis media. In: Bluestone CD, Stool SE,editors. Pediatric otolaryngology. 3rd ed. Philadelphia: Saunders; 2003. p. 687.
  • Fitzwater S, Chandran A, Santosham M, Johnson H. The worldwide impact of the seven-valent pneumococcal conjugate vaccine. The Pediatric Infectious Disease Journal. 2012;31(5):501–08. doi:10.1097/INF.0b013e31824de9f6.
  • Moore MR, Link-Gelles R, Schaffner W, Lynfield R, Holtzman C, Harrison LH, Zansky SM, Rosen JB, Reingold A, Scherzinger K, et al. Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease in children in the USA: a matched case control study. Lancet Respir Med. 2016;4:399–406. doi:10.1016/S2213-2600(16)00052-7.
  • Cohen R, Levy C, Bingen E, Koskas M, Nave I, Varon E. Impact of 13-valent pneumococcal conjugate vaccine on pneumococcal nasopharyngeal carriage in children with acute otitis media. Pediatr Infect Dis J. 2012;31:297–301. doi:10.1097/INF.0b013e318247ef84.
  • Ceyhan M, Ozsurekci Y, Gurler N, Oksuz L, Aydemir S, Ozkan S, Aydemir S, Ozkan S, Yuksekkaya S, Keser Emiroglu M, et al. Serotype distribution of Streptococcus pneumoniae in children with invasive diseases in Turkey: 2008–2014. Hum Vaccin Immunother. 2016;12(2):308–13. doi:10.1080/21645515.2015.1078952.
  • Dagan R, Klugman KP. Impact of conjugate pneumococcal vaccines on antibiotic resistance. Lancet Infect Dis. 2008;8:785–95. doi:10.1016/S1473-3099(08)70281-0.
  • Potin M, Fica A, Wilhem J, Cerda J, Contreras L, Escobar C, Moreno G, Muñoz A, Véliz L. Statement of the Advisory Immunization Committee of the Chilean Society of Infectious Diseases on the emergence of serotype 19A pneumococcal infectionand the use of pneumococcal conjugated vaccine in Chilean children. Rev Chilena Infectol. 2016;33:304–06. doi:10.4067/S0716-10182016000300009.
  • Institute of Environmental Science and Research Ltd (ESR). Invasive pneumococcal disease in New Zealand. Wellington (NZ): Ministry ofHealth; 2014. [accessed 2017 Aug 4]. https://surv.esr.cri.nz/PDF_surveillance/IPD/2014/2014IPDAnnualReport.pdf.
  • Kempf M, Varon E, Lepoutre A, Gravet A, Baraduc R, Brun M, Chardon H, Cremniter J, Croizé J, Dalmay F, et al. Decline in antibiotic resistanceand changes in the serotype distribution of Streptococcus pneumoniaeisolates from children with acute otitis media; a 2001–2011 survey by the French Pneumococcal Network. Clin Microbiol Infect. 2015;21:35–42. doi:10.1016/j.cmi.2014.08.009.
  • Rudolph K, Bruce M, Bulkow L, Singleton R, Zulz T, Gounder P, Hurlburt D, Bruden D, Hennessy T, Rudolph K, et al. Clonal diversity of penicilin nonsusceptible invasive pneumococal isolates in Alaska, 2001–2014. Presented at: 10th International Symposium on Pneumococci and Pneumococcal Disease (ISPPD); 2016; Glasgow, Scotland, UK

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.